Wednesday, November 19, 2025
Tokat Gaziosmanpaşa University (TOGÜ) Faculty of Pharmacy has added a new milestone to its R&D efforts shaping the future of health sciences. The "Hybrid Nanoparticle Formulations," developed by our faculty member Asst. Prof. Dr. Nihat Kurt in collaboration with Hacettepe University and Koç University, has been registered by the Turkish Patent and Trademark Office under the number 2023 015162 and granted patent protection.
The "Rational" Era in Treatment Processes
This registered invention offers an innovative solution to the challenges encountered in classical drug therapies through rational drug design. Thanks to the developed hybrid nanoparticle technology, the drug is transported safely and directly to the targeted tissue, rather than dispersing throughout the body after administration.
Considered a significant step in the field of pharmaceutical technology, this study stands out with several advantages:
From Science to Production
Developed in line with our university's research vision, this patented technology is aimed to be introduced to the pharmaceutical industry in the coming period and to serve as a model for domestic drug development processes.
We sincerely congratulate Asst. Prof. Dr. Nihat Kurt, Head of the Department of Pharmaceutical Technology, on the successful patent registration of his work titled "Hybrid Nanoparticle Formulations."
We thank our esteemed faculty member, who raises the scientific standards of our faculty through strong collaborations with different universities and the innovative technologies he develops, for his contributions to science and humanity, and we wish him continued and increasing success.